Electrical Equipment & Parts
Compare Stocks
2 / 10Stock Comparison
XPON vs CBAT
Revenue, margins, valuation, and 5-year total return — side by side.
Electrical Equipment & Parts
XPON vs CBAT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Electrical Equipment & Parts | Electrical Equipment & Parts |
| Market Cap | $422K | $70M |
| Revenue (TTM) | $9M | $162M |
| Net Income (TTM) | $-2M | $-7M |
| Gross Margin | 21.8% | 10.8% |
| Operating Margin | -70.9% | -10.5% |
| Forward P/E | — | 6.0x |
| Total Debt | $1M | $30M |
| Cash & Equiv. | $548K | $7M |
XPON vs CBAT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 22 | May 26 | Return |
|---|---|---|---|
| Expion360 Inc. (XPON) | 100 | 0.2 | -99.8% |
| CBAK Energy Technol… (CBAT) | 100 | 71.2 | -28.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: XPON vs CBAT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
XPON is the clearest fit if your priority is growth exposure.
- Rev growth -6.0%, EPS growth -18.5%, 3Y rev CAGR 7.6%
- -6.0% revenue growth vs CBAT's -13.6%
CBAT carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 1.05
- -69.9% 10Y total return vs XPON's -99.9%
- Lower volatility, beta 1.05, Low D/E 25.1%, current ratio 0.82x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -6.0% revenue growth vs CBAT's -13.6% | |
| Quality / Margins | -4.0% margin vs XPON's -21.8% | |
| Stability / Safety | Beta 1.05 vs XPON's 3.34, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -6.9% vs XPON's -23.9% | |
| Efficiency (ROA) | -2.0% ROA vs XPON's -19.2%, ROIC 4.6% vs -97.6% |
XPON vs CBAT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
XPON vs CBAT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CBAT leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
CBAT is the larger business by revenue, generating $162M annually — 17.2x XPON's $9M. CBAT is the more profitable business, keeping -4.0% of every revenue dollar as net income compared to XPON's -21.8%. On growth, XPON holds the edge at +72.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $9M | $162M |
| EBITDAEarnings before interest/tax | -$7M | -$8M |
| Net IncomeAfter-tax profit | -$2M | -$7M |
| Free Cash FlowCash after capex | -$7M | -$8M |
| Gross MarginGross profit ÷ Revenue | +21.8% | +10.8% |
| Operating MarginEBIT ÷ Revenue | -70.9% | -10.5% |
| Net MarginNet income ÷ Revenue | -21.8% | -4.0% |
| FCF MarginFCF ÷ Revenue | -70.6% | -5.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +72.2% | +36.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +100.4% | — |
Valuation Metrics
XPON leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $422,426 | $70M |
| Enterprise ValueMkt cap + debt − cash | $903,948 | $94M |
| Trailing P/EPrice ÷ TTM EPS | -0.03x | 6.04x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 5.22x |
| Price / SalesMarket cap ÷ Revenue | 0.08x | 0.40x |
| Price / BookPrice ÷ Book value/share | 0.17x | 0.59x |
| Price / FCFMarket cap ÷ FCF | — | 3.13x |
Profitability & Efficiency
CBAT leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
CBAT delivers a -5.5% return on equity — every $100 of shareholder capital generates $-6 in annual profit, vs $-23 for XPON. CBAT carries lower financial leverage with a 0.25x debt-to-equity ratio, signaling a more conservative balance sheet compared to XPON's 0.41x. On the Piotroski fundamental quality scale (0–9), CBAT scores 7/9 vs XPON's 4/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -22.7% | -5.5% |
| ROA (TTM)Return on assets | -19.2% | -2.0% |
| ROICReturn on invested capital | -97.6% | +4.6% |
| ROCEReturn on capital employed | -121.2% | +7.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 |
| Debt / EquityFinancial leverage | 0.41x | 0.25x |
| Net DebtTotal debt minus cash | $481,522 | $23M |
| Cash & Equiv.Liquid assets | $547,565 | $7M |
| Total DebtShort + long-term debt | $1M | $30M |
| Interest CoverageEBIT ÷ Interest expense | -108.10x | -24.86x |
Total Returns (Dividends Reinvested)
CBAT leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CBAT five years ago would be worth $1,901 today (with dividends reinvested), compared to $8 for XPON. Over the past 12 months, CBAT leads with a -6.9% total return vs XPON's -23.9%. The 3-year compound annual growth rate (CAGR) favors CBAT at 0.7% vs XPON's -89.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -18.6% | -8.7% |
| 1-Year ReturnPast 12 months | -23.9% | -6.9% |
| 3-Year ReturnCumulative with dividends | -99.9% | +2.0% |
| 5-Year ReturnCumulative with dividends | -99.9% | -81.0% |
| 10-Year ReturnCumulative with dividends | -99.9% | -69.9% |
| CAGR (3Y)Annualised 3-year return | -89.5% | +0.7% |
Risk & Volatility
CBAT leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CBAT is the less volatile stock with a 1.05 beta — it tends to amplify market swings less than XPON's 3.34 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CBAT currently trades 62.8% from its 52-week high vs XPON's 12.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.20x | 1.01x |
| 52-Week HighHighest price in past year | $5.50 | $1.25 |
| 52-Week LowLowest price in past year | $0.49 | $0.77 |
| % of 52W HighCurrent price vs 52-week peak | +12.0% | +62.8% |
| RSI (14)Momentum oscillator 0–100 | 44.5 | 39.6 |
| Avg Volume (50D)Average daily shares traded | 195K | 111K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
CBAT leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). XPON leads in 1 (Valuation Metrics).
XPON vs CBAT: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is XPON or CBAT a better buy right now?
For growth investors, Expion360 Inc.
(XPON) is the stronger pick with -6. 0% revenue growth year-over-year, versus -13. 6% for CBAK Energy Technology, Inc. (CBAT). CBAK Energy Technology, Inc. (CBAT) offers the better valuation at 6. 0x trailing P/E, making it the more compelling value choice. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — XPON or CBAT?
Over the past 5 years, CBAK Energy Technology, Inc.
(CBAT) delivered a total return of -81. 0%, compared to -99. 9% for Expion360 Inc. (XPON). Over 10 years, the gap is even starker: CBAT returned -69. 7% versus XPON's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — XPON or CBAT?
By beta (market sensitivity over 5 years), CBAK Energy Technology, Inc.
(CBAT) is the lower-risk stock at 1. 01β versus Expion360 Inc. 's 3. 20β — meaning XPON is approximately 218% more volatile than CBAT relative to the S&P 500. On balance sheet safety, CBAK Energy Technology, Inc. (CBAT) carries a lower debt/equity ratio of 25% versus 41% for Expion360 Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — XPON or CBAT?
By revenue growth (latest reported year), Expion360 Inc.
(XPON) is pulling ahead at -6. 0% versus -13. 6% for CBAK Energy Technology, Inc. (CBAT). On earnings-per-share growth, the picture is similar: CBAK Energy Technology, Inc. grew EPS 574. 5% year-over-year, compared to -1847. 2% for Expion360 Inc.. Over a 3-year CAGR, CBAT leads at 49. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — XPON or CBAT?
CBAK Energy Technology, Inc.
(CBAT) is the more profitable company, earning 6. 7% net margin versus -239. 6% for Expion360 Inc. — meaning it keeps 6. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CBAT leads at 5. 0% versus -120. 1% for XPON. At the gross margin level — before operating expenses — CBAT leads at 23. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — XPON or CBAT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is XPON or CBAT better for a retirement portfolio?
For long-horizon retirement investors, CBAK Energy Technology, Inc.
(CBAT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 01)). Expion360 Inc. (XPON) carries a higher beta of 3. 20 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CBAT: -69. 7%, XPON: -99. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between XPON and CBAT?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: XPON is a small-cap quality compounder stock; CBAT is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.